Metomni R XL 25/2.5: Notes for Doctors and Pharmacists
Metomni R XL 25/2.5: Metoprolol Succinate (SR) & Ramipril Tablets
A practical reference for prescribers, pharmacists and distributors handling Metomni R XL 25/2.5, covering Schedule H requirements, counselling points and supply enquiries.
Product reference for the counter
- Brand: Metomni R XL 25/2.5, marketed by EMK Omni Pharma, Mysuru, Karnataka
- Generic: Metoprolol Succinate (SR) and Ramipril Tablets
- Composition: Metoprolol Succinate IP 23.75 mg (equivalent to Metoprolol Tartrate 25 mg) in sustained release form and Ramipril IP 2.5 mg, with approved excipients
- Dosage form: film-coated sustained release tablet
- Pack: 10 x 10 tablets
- Therapeutic area: blood pressure management, cardiovascular care
- Regulatory status: Schedule H prescription drug
- Storage per label: cool, dry and dark place, protected from light
The product is contract manufactured at GMP certified units for EMK Omni Pharma and supplied under the company's brand.
Schedule H handling and dispensing
Metomni R XL 25/2.5 carries the standard warning: not to be sold by retail without the prescription of a registered medical practitioner.
At dispensing, verify that the prescription is legible, dated and carries the prescriber's name, qualification and registration details, along with the patient's name. Confirm that the strength written matches the pack, since the range includes single molecule products with similar names.
Maintain the prescription record as required under the Drugs and Cosmetics Rules, and record batch and quantity supplied in your dispensing register.
Do not substitute a different composition at the counter. Where the exact product is unavailable, refer the patient back to the prescriber for a documented alternative rather than making the change at the pharmacy.
Cut strips should be avoided where possible. Where a partial strip is supplied, ensure batch number, manufacturing date, expiry date and the marketer name remain visible on the portion given to the patient.
Patient counselling checklist
A short structured conversation at the counter improves adherence and catches risk early.
- Swallow whole. Explain that the sustained release tablet must not be chewed, crushed or split
- Same time daily. Reinforce a fixed routine and a consistent relationship to meals
- Missed dose. Take when remembered unless the next dose is near, and never double
- Do not stop abruptly. Explain rebound risk with beta blockers and the need for a supervised taper
- First dose effects. Warn about light headedness on standing, particularly at the start and after dose changes
- Dry cough. Explain that a persistent dry cough may relate to the ACE inhibitor and should be reported rather than self treated
- Angioedema. Facial, lip or tongue swelling and breathing difficulty require emergency care
- Pregnancy. Ask about pregnancy or plans; ACE inhibitors are not used in pregnancy
- Self medication check. Ask specifically about NSAID painkillers, potassium supplements, potassium based salt substitutes and cold remedies containing decongestants
- Diabetes. Note that beta blockade can mask some hypoglycaemia warning signs
- Monitoring. Remind the patient about kidney function and potassium testing, and home blood pressure records
- Storage. Advise a cool, dry, dark place, away from the bathroom and away from direct sun
Storage and stock rotation at the pharmacy
Store cartons in the cool, dry, dark conditions stated on the label, away from windows, exterior walls that heat up and any area near equipment that gives off warmth.
During the monsoon, monitor humidity in the storage area and keep cartons off the floor on shelving that allows air movement. Damaged, damp or discoloured cartons should be quarantined rather than dispensed.
Rotate stock on a first expiry first out basis and check expiry dates during regular stock review. Segregate expired and returned stock in a clearly marked area pending disposal through the approved route.
Where a patient reports a suspect pack, a damaged blister or an unusual appearance, retain the pack, note the batch number and expiry, and raise it with the supplier so it can be traced.
Availability and distribution enquiries
Pharmacies, hospitals, clinics and distributors can contact EMK Omni Pharma directly for availability, product information, stockist details and distribution enquiries for Metomni R XL 25/2.5 and the rest of the cardiovascular range.
- WhatsApp: +91 94487 74372
- Website: the contact page at emkomnipharma.com
- Based at: Mysuru, Karnataka
EMK Omni Pharma markets the product; manufacturing is carried out at GMP certified facilities on the company's behalf. Requests for the current product list, pack details and supply terms can be made through the contact page or on WhatsApp.
Healthcare professionals are encouraged to report suspected adverse drug reactions through the national pharmacovigilance programme, and to inform the marketer so that the report can be recorded.
This article is for general information only and is not a substitute for advice from a registered medical practitioner.
Frequently asked questions
- Can Metomni R XL 25/2.5 be dispensed on a repeat request without a fresh prescription?
- It is a Schedule H drug, so dispensing requires a valid prescription from a registered medical practitioner and appropriate record keeping at the pharmacy.
- What is the most important counselling point for this product?
- Two stand out: swallow the sustained release tablet whole, and never stop the beta blocker abruptly without medical supervision.
- Which over the counter purchases should pharmacists ask about?
- NSAID painkillers, potassium supplements, potassium based salt substitutes and decongestant cold remedies are the most relevant to flag.
- How should a suspected adverse reaction be handled?
- Advise the patient to consult the prescriber, report through the national pharmacovigilance programme, and inform EMK Omni Pharma with the batch details.
- How can a distributor enquire about the cardiovascular range?
- Distributors can use the contact page on the EMK Omni Pharma website or message the company on WhatsApp at +91 94487 74372.
- Does EMK Omni Pharma manufacture this product?
- EMK Omni Pharma markets the product. Manufacturing is carried out at GMP certified contract facilities on the company's behalf.
Need Metomni R XL 25/2.5 for your pharmacy, hospital or clinic?
EMK Omni Pharma supplies through authorised channels across Karnataka. Send an enquiry and our team will respond during business hours.
Related guides
Medical Disclaimer
This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.